Overview

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The study will assess the use of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to a protocol-defined treatment failure over 15 months, in patients diagnosed with schizophrenia who have been incarcerated.
Phase:
Phase 4
Details
Lead Sponsor:
Janssen Scientific Affairs, LLC
Treatments:
Aripiprazole
Olanzapine
Paliperidone Palmitate
Perphenazine
Quetiapine Fumarate
Risperidone